Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 228,805 | 658,537 | 706,959 | 759,544 | 240,335 |
| Marketable Securities | 360,643 | N/A | N/A | N/A | N/A |
| Receivables | 15 | N/A | N/A | N/A | N/A |
| Inventories | 4,138 | N/A | N/A | N/A | N/A |
| TOTAL | $660,929 | $718,114 | $758,600 | $804,298 | $275,302 |
| Non-Current Assets | |||||
| PPE Net | 49,553 | 44,258 | 32,860 | 33,414 | 34,862 |
| Intangibles | 12,373 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 59,870 | 65,118 | 62,160 | 63,724 | 65,217 |
| TOTAL | $121,796 | $109,376 | $95,020 | $97,138 | $100,079 |
| Total Assets | $782,725 | $827,490 | $853,620 | $901,436 | $375,381 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,969 | 1,418 | 1,098 | 1,399 | 103 |
| Accrued Expenses | 52,276 | 47,488 | 35,579 | 37,768 | 39,581 |
| Other current liabilities | 3,500 | N/A | N/A | N/A | N/A |
| TOTAL | $60,743 | $52,474 | $40,904 | $43,985 | $44,737 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 294,657 | 298,051 | 239,078 | 275,421 | 171,256 |
| TOTAL | $294,657 | $298,051 | $284,872 | $275,421 | $219,170 |
| Total Liabilities | $355,400 | $350,525 | $325,776 | $319,406 | $263,907 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 266,129 | 266,122 | 266,095 | 266,036 | 174,101 |
| Common Shares | 12 | 12 | 12 | 12 | 8 |
| Retained earnings | -1,099,224 | -1,071,618 | -989,524 | -931,252 | -878,562 |
| Other shareholders' equity | -29,056 | -780 | -27,790 | -28,816 | -28,874 |
| TOTAL | $427,325 | $476,965 | $527,844 | $582,030 | $111,474 |
| Total Liabilities And Equity | $782,725 | $827,490 | $853,620 | $901,436 | $375,381 |